Key result
Although a 'strike early and strong' approach to lipid lowering in ACS seems reasonable, there are currently no randomized clinical trials demonstrating that it improves clinical outcomes.
Why the study?
Does early intensive lipid lowering improve clinical outcomes in patients after acute coronary syndrome?
Does early intensive lipid lowering improve clinical outcomes in patients after acute coronary syndrome?
The authors highlight a lack of randomized clinical trial evidence supporting the expert consensus recommendation for early intensive lipid lowering post-ACS.
A working group, with representatives from the European Association of Preventive Cardiology and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy, state in a position paper that a 'strike early and strong' approach is needed in patients after acute coronary syndrome (ACS). 1 Although this approach seems reasonable, there are no randomized clinical trials (RCTs) demonstrating that the approach improves clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Harvey D. White (2022) conducted a letter in Acute coronary syndrome (ACS). Early intensive lipid lowering ('strike early and strong' approach) was evaluated. Although a 'strike early and strong' approach to lipid lowering in ACS seems reasonable, there are currently no randomized clinical trials demonstrating that it improves clinical outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: